GO
Loading...

Drug Retail

More

  • Rite Aid cuts full-year profit forecast; shares fall Thursday, 19 Dec 2013 | 12:29 PM ET

    Dec 19- Rite Aid Corp, the third-largest U.S. drugstore chain, cut its full-year profit forecast, mainly due to Medicare reimbursement cuts and higher cost of some generic drugs, sending the company's shares down as much as 11 percent. Rite Aid cut its full-year profit forecast to 17- 23 cents per share from 18- 27 cents per share.

  • Under ACA, payments to doctors made public     Tuesday, 17 Dec 2013 | 1:17 PM ET

    CNBC's Sara Eisen reports GlaxoSmithKline is becoming the first to stop paying doctors to promote drugs.

  • Dec 10- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10- year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market.

  • Dec 10- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc said on Tuesday they would form the largest U.S. generic drug sourcing operation in a 10- year agreement to serve the world's biggest market for generic drugs. The 50-50 joint venture will be operational as soon as July 1, 2014.

  • Cramer: ‘I’m throwing up my hands with this group’ Wednesday, 4 Dec 2013 | 11:16 AM ET

    Muddled by inconsistent earnings and stock performances, one sector appears tougher and tougher to predict, CNBC's Jim Cramer says.

  • *Ontario ban could be imitated by other provinces. Pharmacy companies saw the private-label drugs as a way to reduce the impact of Ontario regulations designed to lower the cost of generic drugs. The Ontario rules have weighed on the earnings of the drugstore chains, including Shoppers Drug Mart Corp, a principal appellant in this case.

  • Rocky Mountain High-er     Friday, 22 Nov 2013 | 10:27 AM ET

    A medical marijuana dispensary in Central City, Colo.—a small gambling town nestled in the mountains near Denver—just became the first business in the United States licensed to sell marijuana to patrons without a note from their doctors.

  • Third party sales pit Amazon vs. JNJ: Report Monday, 11 Nov 2013 | 8:37 AM ET

    Amazon.com is clashing with Johnson & Johnson amid complaints the online retailer hasn't stopped sales of damaged or expired products.

  • Nov 5- CVS Caremark Corp raised its profit forecast for the year on Tuesday, as sales grew at its drugstore chain and it processed more prescriptions from new clients. Wall Street analysts expected $31.53 billion, according to Thomson Reuters I/B/E/S.

  • CVS Caremark raises outlook after higher Q3 profit Tuesday, 5 Nov 2013 | 7:13 AM ET

    Nov 5- CVS Caremark Corp posted higher quarterly profit and raised its forecast for the year on Tuesday, as sales grew at its drugstore chain and it processed more prescriptions.

  • Francois Nader, NPS Pharmaceuticals president & CEO, discusses its lead product Gattex for "short bowel syndrome," the potential for Netpara and the solid performance of its stock.

  • 'Pot Mom' pleads guilty     Wednesday, 9 Oct 2013 | 1:32 PM ET

    The so-called "pot mom" Andrea Sanderlin has confessed to a judge she operated a facility in which she and others grew at least 1,000 marijuana plants and sold the products. CNBC's Andrea Day has the details.

  • Drugstores aim to be one-stop Obamacare shop Thursday, 3 Oct 2013 | 11:47 AM ET
    A sign offering help for customers with questions about the Affordable Care Act hangs in a pharmacy in Wheeling, Illinois.

    Drugstores signed on to help educate consumers about Obamacare, but they have their sights set on the future business of these newly insured consumers.

  • L'Oreal on Nestle deal: 'This is business fiction' Friday, 30 Aug 2013 | 2:01 AM ET
    Jean-Paul Agon, chief executive officer of L'Oreal SA

    L'Oreal's rumored buyback of Nestle's 29.5 percent stake in the French cosmetics giant looked far from a done deal on Friday, with Jean-Paul Agon, chairman and CEO of L'Oreal, telling CNBC that the ball was in the Swiss food giant's court.

  • DOJ will not block state pot laws     Thursday, 29 Aug 2013 | 2:49 PM ET

    The Department of Justice will not block state marijuana laws if distribution is regulated, reports CNBC's Eamon Javers.

  • Scammers target pot stocks     Tuesday, 20 Aug 2013 | 1:58 PM ET

    FINRA is issuing a new investor alert called "marijuana stock scams." CNBC's Mary Thompson offers insight.

  • 'High' taxes     Thursday, 15 Aug 2013 | 1:55 PM ET

    Washington will tax pot anywhere from 25 to 50 percent at the production and processor level, another 25 percent at retail. CNBC's Jane Wells reports Washington says it could raise up to $2 billion in pot taxes over five years.

  • Pot entrepreneurs invest in the 'green rush'     Thursday, 15 Aug 2013 | 12:00 AM ET

    CNBC's Jane Wells reports from the River Rock Wellness Center in Denver, Colorado, where in 5 months legal medical cannabis will be able to be sold as recreational pot. Investors are hoping to cash in on the "green rush," she says.

  • Wake up and smell the coffee – market may perk up Wednesday, 14 Aug 2013 | 8:58 AM ET

    The global coffee market has been rather decaffeinated for the past couple of years, with prices falling to less than half their 2011 peak and the bean becoming the worst-performing soft commodity last year.

  • Ending the war on drugs     Monday, 12 Aug 2013 | 7:00 PM ET

    NBC's Steve Handelsman reports the U.S. has 25 percent of the world's prisoners; and Joseph diGenova, Former U.S. Attorney, and Matt Welch, Reason Magazine, discuss a drug policy overhaul. "The science of marijuana is very bad," says diGenova, adding "that doesn't mean we should lock people up forever who use it."

Most Popular Video

Thursday, 17 Apr 2014 | 6:40 PM ET

Mad Money's Jim Cramer reflects on CNBC's evolution over the past 25 years.

Thursday, 17 Apr 2014 | 6:30 PM ET

The latest cybersecurity headlines- tax scammers have no deadline, and the Heartbleed vulnerability threatens websites. CNBC's Scott Cohn reports.

Thursday, 17 Apr 2014 | 6:25 PM ET

John McAvoy, president and CEO of Consolidated Edison, discusses the state of the business with Mad Money host Jim Cramer.